BioNJ's C-Suite Summit: October 10

Against a backdrop of change, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change.

Our growing list of esteemed speakers includes:

Britt Byers, Sr. Vice President, Human Resources NA, Kyowa Kirin
Vikki Conway, Sr. Vice President Head of Human Resources US, Teva Pharmaceuticals
Kiran Dattani, Customer Success - Transformation - Strategy – Architecture, Google Cloud Healthcare and Life Sciences, Google
Tom Evegan, Principal, Strategy & Management Consulting; National Consulting Leader Life Sciences, RSM
The Hon. Jim Greenwood, Former Congressman & Former President & CEO, BIO
Hisham Hamadeh, Ph.D., Sr. Vice President & Global Head, Data Science & AI, Genmab
Garrett Ingram, President & CEO, Cipla Therapeutics
Harriet Keane, Partner, McKinsey & Company
Keith Koharski, Executive Director, Global Development IT, Regeneron
Emer Leahy, Ph.D., MBA, President & CEO PsychoGenics & Chair, BioNJ
Lisa LeCointe-Cephas, J.D., Partner, Compliance & Investigations & Global Chair, Life Sciences Sector, DLA Piper
Will Lewis, J.D., MBA, Chair & CEO, Insmed
Husseini Manji, M.D., F.R.C.P.C., Professor, Oxford University; Visiting Professor, Duke University; Co-Chair, UK Govt Mental Health Mission; Former Global Therapeutic Area Head, Neuroscience, Johnson & Johnson; and Former Chief, Laboratory of Molecular Pathophysiology & Experimental Therapeutics, National Institute of Mental Health (NIMH)
Heather Meade, J.D., Principal, EY
Clive Meanwell, M.D., Chairman & Partner, Population Health Partners
Aamir Mecklai, Managing Director, Healthcare Investment Banking, Bank of America
Christopher Mortko, Ph.D., MBA, Vice President, Business Development & Licensing, Merck
Gina Murdoch, MBA, President & CEO, Multiple Sclerosis Association of America
Brandon Parry, Sr. Partner, McKinsey & Company
Tarek Rabah, President & CEO, Otsuka Pharmaceuticals
Deiva Ramachandran, Ph.D., Partner, Generative AI-Automation Practice Leader, Healthcare, Life Sciences, State and Local Govt., IBM
Arda Ural, Ph.D., Partner and Americas Industry Market Leader for Life Sciences and Healthcare, EY
Monika Vnuk, M.D., Sr. Vice President, Global Partnering & Business Development, Sanofi
Scott White, MBA, Chief Operations Officer, NA Innovative Medicine, Johnson & Johnson

Check out the action-packed agenda!

7:30 a.m. – 8:15 a.m.

Registration & Networking Breakfast

8:15 a.m. – 8:20 a.m.

Welcome & Opening Remarks

INNOVATION

8:20 a.m. – 8:50 a.m.

Keynote: The Next Wave of Innovation in Life Sciences

8:50 a.m. – 9:45 a.m.

Panel: Harnessing Change to Deliver Impactful Innovation

POLICY

9:45 a.m. – 10:15 a.m.

Fireside Chat: Policy Uncertainties in an Election Year

10:15 a.m. – 10:30 a.m.

Networking Break

MARKET ACCESS

10:30 a.m. – 11:15 a.m.

Panel: Market Access & Reimbursement

HEALTH EQUITY & TALENT

11:15 a.m. – 12:00 p.m.

Panel: Topics in Talent: Attraction, Retention & Diversity

12:00 p.m. – 12:30 p.m.

Fireside Chat: Research & Development in Mental Health

12:30 p.m. – 1:30 p.m.

Networking Lunch

COMMERCIALIZATION & PATIENT SERVICES

1:30 p.m. – 2:15 p.m.

Panel: Continued Evolutions in Go-to-Market Models Including Patient Services

2:15 p.m. – 3:00 p.m.

Panel: Evolving Capital Markets & Implications for Innovation

3:00 p.m. – 3:45 p.m.

Panel: The Digital & AI Era in the Biopharma Industry: How Can Companies Across Functions Transition from Hype Into Reality?

3:45 p.m. – 4:00 p.m.

Closing Remarks

4:00 p.m. – 4:30 p.m.

Networking Reception

Join us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to maintain our pricing for the third year in a row.) Click here to register.

Thank You to Our Sponsors

Visit www.BioNJ.org for information.

This promotion was sent by BioNJ.